Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Quinoline derivative, preparation method and medical use thereof

A derivative, quinoline technology, applied in the field of treatment of tumor diseases, can solve problems such as signal transduction disorders

Inactive Publication Date: 2007-08-08
CHINA PHARM UNIV
View PDF0 Cites 32 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in some cases, as a result of mutations or overexpression, signaling mediated by PTKs is dysregulated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinoline derivative, preparation method and medical use thereof
  • Quinoline derivative, preparation method and medical use thereof
  • Quinoline derivative, preparation method and medical use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0112] 3-Isopropoxy-4-methylnitrobenzene (1)

[0113] Add 60g (0.39mol) of 3-hydroxy-4-methylnitrobenzene and 100g (0.72mol) of potassium carbonate into a 500ml three-necked flask, dissolve in 300ml of acetone, stir mechanically, and slowly add 50ml of 2-bromopropane ( 0.50mol), react at 40°C for 6 hours. Then the reaction liquid was poured into 1000 ml of water, extracted three times with chloroform, the extract was concentrated, and vacuum-dried to obtain 72.2 g of a brownish-yellow liquid product with a yield of 95%. Molecular formula: C10H13NO3, molecular weight: 195.22

[0114] MS (EI) m / z 195.

Embodiment 2

[0116] 3-isopropoxy-4-methylaniline (2)

[0117] Add 41g (0.73mol) of iron powder, 200ml of water, 50ml of acetic acid and 50ml of ethanol into a 500ml three-necked flask, stir and heat to 30°C for 20min, then slowly drop 3-isopropoxy-4-methylnitrate 60 g (0.31 mol) of phenylbenzene was reacted at 50° C. for 2 hours, suction filtered, the combined filtrates were extracted with chloroform three times, the extract was concentrated, and vacuum-dried to obtain 45 g of a brown oily liquid. Yield 89%. Molecular formula: C10H15NO, molecular weight: 165.24.

[0118] MS (EI) m / z 165.

Embodiment 3

[0120] (Z)-2-Nitryl-3-(3-isopropoxy-4-methylphenyl-amino)-acrylic acid ethyl ester (3)

[0121] Add 45g (0.27mol) of 3-isopropoxy-4-methylaniline, 51g (0.30mol) of (Z)-3-ethoxy-2-nitrile-acrylic acid ethyl ester and 160ml of toluene into a 250ml three-necked flask , heated and stirred, refluxed for 4 hours, cooled to room temperature, a large amount of white solid was precipitated, filtered with suction, recovered toluene in the filtrate, and the filter cake was recrystallized with ethanol to obtain 72 g of the product with a yield of 93%. Molecular formula: C16H20N2O3, molecular weight: 288.35. Mp: 138°C.

[0122] MS (EI) m / z 288.

[0123] 1 H-NMR (AV-500, δ, DMSO-d 6 ): 1.21-1.28(m, 9H); 2.08(s, 3H); 4.14-4.26(t, 2H); 4.55-4.57(m, 1H); 6.81-6.89(m, 2H); 7.01-7.02(d , 1H); 8.26-8.39(t, 1H); 10.58-10.68(d, 1H)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a making method of compound I and drug composition and application to treat tumour, which is 3-nitrile quinoline derivant (I) as dual-inhibitor protein kinase of tyrosine and nitric oxide synthase, wherein G1, G2, G3, G4, X, Z and n are defined as instruction.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a class of 3-cyanoquinoline derivatives which are dual inhibitors of tyrosine protein kinase and nitric oxide synthase. The invention also discloses its preparation method and a pharmaceutical composition containing it. And the purposes for treating tumor diseases. Background technique [0002] Protein tyrosine kinase (PTK) is a family of protein kinases that can catalyze the transfer of γ-phosphate on ATP or GTP from the donor to the acceptor tyrosine residue of the protein substrate. Cell regulatory processes (e.g. mitosis, cell differentiation, development, tumor formation, angiogenesis, apoptosis, cell formation and adhesion, cell cycle regulation, cell growth regulation, T and B cell activation, response to extracellular stimuli, neural Transmitter signaling, platelet activation, transcriptional regulation, glucose uptake) play an important role. However, in some cases, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D417/12C07D401/12A61K31/4709A61P35/00
Inventor 尤启冬曹鑫刘晓蓉李志裕陆小云
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com